Organization
Endologix, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Endologix, Inc.
... Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Endologix, Inc. (NasdaqGS: ELGX). On August 2, 2016, the Company issued a press release ...
... to the investment community. Today we are offering reports on DXTR, EKSO, ELGX, and BDX which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. ...
... Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, ...
... latest key findings for all current investors, traders, and shareholders of Endologix, Inc. (NASDAQ:ELGX), Haemonetics Corporation (NYSE:HAE), Prudential Financial, Inc. (NYSE:PRU), AdvanSix Inc. (NYSE:ASIX), PolyOne ...
... Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Endologix, Inc. (NasdaqGS: ELGX). On August 2, 2016, the Company issued a press release ...
... Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Endologix, Inc. (NasdaqGS: ELGX). On August 2, 2016, the Company issued a press release ...
... Robbins Arroyo LLP is investigating whether certain officers and directors of Endologix, Inc. (NasdaqGS: ELGX) breached their fiduciary duties to shareholders. Endologix develops, manufactures, markets, ...
... If you want a Stock Review on ELGX, DXTR, BDX, or EKSO then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today ...
... Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today ...
... Endologix, Inc.(Nasdaq:ELGX) ("Endologix"), a developer and marketer of innovative treatments for aortic disorders, ...
... nominally significant p In a pre-specified pooled analysis of the SUNBEAM and RADIANCE(TM) Part B studies, ozanimod did not reach statistical significance compared with IFN ...
... Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today ...
... Celgene Inflammation and Immunology. Full results from the phase III SUNBEAM(TM) and RADIANCE(TM) Part B studies evaluating two doses of oral ozanimod compared with Avonex® ...
... Endologix, Inc.(Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced ...
... HighRadius Corporation has officially opened registration for Radiance 2018, the 5th Annual Credit and Accounts Receivable Innovation Conference hosted at ...
... Endologix, Inc.(Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today ...
... Endologix, Inc.(Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced ...
... litigation firm, is investigating whether certain officers and directors of Cardiovascular Systems, Inc. ("Cardiovascular Systems" or the "Company") (NASDAQ: CSII) breached their fiduciary duties owed ...
... Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, ...
... been instrumental in several product launches, including Medtronic's Endurant stent graft and Endologix' Nellix endovascular aneurysm sealing system. He joins Lombard from Endologix (NASDAQ: ELGX) ...
... in women compared to men treated with the Ovation stent graft system (Endologix) for elective abdominal aortic aneurysm repair. The 30-day results of the 76 ...
Want to see the full history on Endologix, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial